They receive grants for interdisciplinary research networks

The networks that receive funding include researchers from several departments and campuses within Karolinska Institutet (KI). With this funding, the networks can develop and conduct interdisciplinary collaborations, including for example, seed funding, researcher mobility, and collaboration with industry, healthcare, and the public sector.

“We are extremely pleased with the great interest and the high quality of the applications. These networks will play a crucial role in creating new research opportunities and deepening collaborations within KI”, says Marie Arsenian Henriksson, Academic Vice President for Research and Chair of the Committee for Research. 

The networks are funded for three years, starting in January 2025, and receive support of SEK 350,000 or 600,000 per year. This gives researchers the opportunity to develop long-term projects and create sustainable networks that promote interdisciplinary research at KI.

Networks receiving funding

Allocated SEK per year is stated in parentheses after each network or organisation. Please note, that some of the names below may change. 

• AutNetKI — Autism Research Network KI (350,000)
• Centre for Allergy Research 2.0 (600,000)
• Centre for Tuberculosis (TB) Research: Improving collaboration opportunities, productivity, and the significance of TB research at KI (350,000)
• FTD-ALS Research Network at Karolinska Institutet (600,000)
• HER MIND: HER Mental Health — interdisciplinary network for innovation and development in women’s mental health (350,000)
• The Infection Biology Network (600,000)
• Interdisciplinary Network for Liver Metastases (350,000)
• Karolinska Institutet’s Network on Movement and Physical Function — from genes to dreams (600,000)
• KiiM — KI Inflammation and Immunology Network (600,000)
• KI Pain Network (600,000)
• KIRCNET — KI Respiration and Circulation Network (600,000)
• EVERNET — KI’s Network for Extracellular Vesicles (600,000)
• KNIMS — Karolinska Neuroimmunology and Multiple Sclerosis Network (600,000)
• PHATE: A KI initiative to accelerate clinical usage of phages in Sweden (350,000)
• Post COVID — the long-term consequences after the pandemic (350,000)